Quest Diagnostics Declares Quarterly Cash Dividend

MADISON, N.J., May 16, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable on July 24, 2017 to shareholders of record of Quest Diagnostics common stock on July 10, 2017.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes.  Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.  Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 43,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

50th Anniversary: In 2017, Quest Diagnostics celebrates 50 years of life-changing results. To learn about our legacy of accomplishments and quest to improve healthcare in the future, visit www.QuestDiagnostics.com/50Years.

For further information: Quest Diagnostics Contacts: Shawn Bevec (Investors): 973-520-2900 or Denny Moynihan (Media): 973-520-2800

SOURCE Quest Diagnostics

Related Links

http://www.questdiagnostics.com